Alkermes plc
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.
Market Cap
$5.0B
Volume
1.8M
Cash and Equivalents
$399.8M
EBITDA
$419.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$1.3B
Profit Margin
84.42%
52 Week High
$36.45
52 Week Low
$22.90
Dividend
N/A
Price / Book Value
3.34
Price / Earnings
14.53
Price / Tangible Book Value
3.54
Enterprise Value
$4.2B
Enterprise Value / EBITDA
9.85
Operating Income
$391.1M
Return on Equity
25.71%
Return on Assets
11.62
Cash and Short Term Investments
$884.0M
Debt
$74.1M
Equity
$1.5B
Revenue
$1.5B
Unlevered FCF
$439.9M
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick PremiumCompany Stock Pitches
No stock pitches match your current filters.
Try adjusting your filters or clearing them and trying again.